EVIDENCE-BASED VALUE OF PD-1 / PD-L1 INHIBITORS IN NSCLC: COMPARISON OF VALUE TO PRICE

被引：0
|
作者：
Doyle, J. J. [1 ]
Wood, B. [1 ]
机构：
[1] IQVIA, New York, NY USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.536
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCP61
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [21] The expression level and prognostic value of PD-L1 and PD-1 in cervical carcinoma patients
    Bao, Yongxing
    Zhang, Songan
    Niyazi, Huerdidan
    Tuluwengjiang, Gulixian
    Zhang, Lei
    Zhang, Yang
    Su, Weipeng
    CANCER RESEARCH, 2017, 77
  • [22] PD-1/PD-L1 inhibitors increase risk of hepatitis
    Reactions Weekly, 2020, 1809 (1) : 9 - 9
  • [23] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    Yi, Ming
    Jiao, Dechao
    Xu, Hanxiao
    Liu, Qian
    Zhao, Weiheng
    Han, Xinwei
    Wu, Kongming
    MOLECULAR CANCER, 2018, 17
  • [24] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 818 - 830
  • [25] Progress on biphenyl derivatives as PD-1/PD-L1 inhibitors
    Wang, Shurong
    Wang, Yuli
    Yan, Hong
    MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (10) : 2089 - 2115
  • [26] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hidetoshi Hayashi
    Kazuhiko Nakagawa
    International Journal of Clinical Oncology, 2020, 25 : 818 - 830
  • [27] Efficiency of PD-1 and PD-L1 Inhibitors in Malignant Therapy
    Gappa, Birgit
    Kobold, Sebastian
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (01) : 7 - 8
  • [28] Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma
    Meghan M. Lynch
    Borislav A. Alexiev
    Brett A. Schroeder
    Seth M. Pollack
    Current Treatment Options in Oncology, 2022, 23 : 1861 - 1876
  • [29] Prognostic value of PD-1/PD-L1 expression in upper tract urothelial carcinoma
    Campedel, L.
    Seisen, T.
    Cussenot, O.
    Comperat, E.
    Varinot, J.
    Roupret, M.
    Cancel-Tassin, G.
    PROGRES EN UROLOGIE, 2018, 28 (16): : 900 - 905
  • [30] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345